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ABSTRACT  A series of stable cell mutants of mouse fibroblasts were previously isolated  (Roos, 
D. S. and  R. L. Davidson,  1980, Somatic  Cell  Genet.,  6:381-390) that exhibit varying degrees 
of resistance to the fusion-inducing effect of polyethylene glycol (PEG), but are morphologically 
similar  to  the  parental  cells  from  which  they  were  derived.  Biochemical  analysis  of these 
mutant cell  lines  has revealed differences  in whole cell lipid  composition  which are directly 
correlated with their susceptibility  to fusion.  Fusion-resistant  cells  contain  elevated  levels  of 
neutral lipids,  particularly triglycerides and an unusual ether-linked  lipid,  O-alkyl, diacylglyc- 
erol. This ether lipid is increased  ~35-fold over parental cells in the most highly PEG-resistant 
cell  line.  Fusion-resistant  cells  also  contain  more  highly  saturated  fatty acyl  chains  (ratio  of 
saturated to  polyunsaturated  fatty acids  [S/P ratio]  ~  4:1) than the  parental  line (S/P ratio ~- 
1:1). Cells  which are  intermediate  in their resistance  to  PEG have  ether lipid  and  fatty acid 
composition  which  is intermediate  between the  parental cells  and the  most fusion-resistant 
mutants.  In a  related  communication  (Roos,  D.  S. and  P.  W.  Choppin,  1985,  J.  Cell.  Biol., 
100:1591-1598) evidence is presented that alteration of lipid content can predictably control 
the fusion  response  of these cells. 
One  of the  most dramatic  forms of membrane-membrane 
interaction  is the  fusion  of cell  membranes (for review see 
references 42 and 52), an event which occurs naturally both 
within  cells,  as required  for cell division,  and between cells 
(e.g., during myogenesis). Cell fusion is also a  characteristic 
feature of certain tumors (23, 79) and viral infections (17, 29, 
55).  Membrane fusion occurs at the subcellular level during 
such events as endocytosis via the coated pit pathway, receptor 
recycling, and  the specific delivery of endogenously synthe- 
sized proteins to appropriate subcellular destinations  (6, 22, 
74).  Despite the biological importance of membrane fusion, 
little is known about either the precise biochemical and bio- 
physical events in  fusion  or the way in  which  cells control 
fusion of their membranes. 
Cell fusion has been studied in vitro in systems often more 
amenable to experimental analysis than  naturally  occurring 
fusion. Many treatments, including viral infections, electrical 
fields,  ionic  manipulations,  lysolecithin,  and  other  mem- 
brane-active  chemicals,  have been  reported  to cause  fusion 
under certain conditions (1, 7, 30, 38, 45, 46, 53, 64, 65, 76, 
80,  85). The polyene polyethylene glycol (PEG) ~ is a  potent 
~Abbreviations  used  in  this paper.  Clone  1D,  5-bromodeoxyuri- 
dine-resistant mouse fibroblast cell line LM (TK-) Clone ID; 1=4, Fs, 
1578 
fusogenic compound that has found wide acceptance as a tool 
for studying mechanisms of cell fusion (7, 39, 54, 77, 81), and 
as a convenient technique for many applications of membrane 
fusion (14, 34, 50). PEG is routinely used for the production 
of hybridomas (16), delivery of various compounds (chemo- 
therapeutic agents, nucleic acids for transfection, etc.) to cells 
(2, 2 l,  4 l,  44,  47,  51),  and a  wide range of experiments in 
somatic cell genetics (13). 
To investigate  cellular factors involved  in  the  control  of 
fusion, we isolated a series of genetically stable, PEG fusion- 
resistant mutants  from a  highly fusible line of mouse L-cell 
fibroblasts (59). The least fusible of these cells exhibit <20% 
fusion under conditions of PEG treatment in which the entire 
monolayer of parental cells fuses into a giant syncytium. The 
selection  procedure  yielded  a  spectrum  of intermediate  fu- 
sion-resistant phenotypes spanning these two extremes which 
have proved very useful in detailed study of the morphology 
of cell fusion (60). We present here data on the direct corre- 
lation between lipid composition and sensitivity to fusion by 
Fir, and F4o, fusion-resistant  cell lines isolated from Clone ID by 4, 
8,  16,  or 40 cycles of polyethylene  glycol-induced fusion;  FAME, 
methyl ester of fatty acid; PEG, polyethylene  glycol; S/P ratio, ratio 
of saturated  to polyunsaturated fatty acids. 
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relationship,  using  defined  alterations  of cellular  lipids  to 
completely control PEG-induced fusion. 
glycolipids, and neutral  lipids, was dried under a stream of nitrogen gas in a 
37"C water bath. Lipids were stored under N2 in tightly sealed tubes or applied 
directly to thin layer chromatographic plates or to columns for liquid chroma- 
tography. 
MATERIALS AND  METHODS 
Cells and Media 
The parental  cell line was the 5-bromodeoxyuridine-resistant  mouse fibro- 
blast cell line LM (TK-) Clone 1D. PEG-resistant derivatives of  Clone 1D were 
isolated by repeated cycles of treatment with PEG followed by passage of those 
cells which remained  unfused (58). PEG-resistant cell lines F4, Fs, F~6, and F4o 
(selected by 4, 8,  16, and 40 cycles of treatment,  respectively) exhibit ~85,  70, 
50, and 20% fusion after exposure to PEG under conditions in which >95% of 
Clone  ID cells fuse (60). Cultures were monitored for mycoplasma contami- 
nation  by  staining  with  Hoechst  33258 and  microscopic  examination  for 
fluorescence (12). Cells were grown in plasticware (Falcon  Labware, Oxnard, 
CA) in reinforced  Eagle's medium containing  4.5  g of glucose per liter and 
supplemented  with 10% fetal bovine serum (Flow Laboratories, Inc., McLean, 
VA). In most experiments, antibiotics were added at concentrations  of 500 U/ 
ml  penicillin  +  0.1  mg/ml streptomycin,  or  50  ug/ml gentamycin  sulfate 
(Schering Corp., Kenilworth, N  J). Cultures were incubated at 37°C in a humid 
atmosphere containing  7% CO2. 
PEC Treatment and Analysis of Fused Cells 
Confluent  monolayers of cells in 60-ram diameter petri dishes were treated 
for 60  s  with  a  50%  solution  of PEG  1000 (J.  T.  Baker  Chemical  Co., 
Phillipsburg, N  J) as previously described (59). After a 2-h incubation  at 37"C 
in  fresh  medium,  cells were fixed, stained,  and  mounted under large glass 
coverslips. The extent of cell fusion in randomly selected fields was quantitated 
by scoring the percentage of all nuclei which were present in fused cells. 
Preparation of Cell Stocks for Chromatography 
Unless otherwise indicated, cells were harvested from late log-phase cultures 
grown in T-flasks or roller bottles by brief trypsinization  or incubation  in  10 
mM EDTA. No differences in lipid content were seen between cells harvested 
with or without trypsin. Typically, -2.5 x  10  7 cells were obtained per 75 cm  2 
T-flasks. Cells were pelleted, washed twice in phosphate-buffered saline, repel- 
leted, and either extracted directly for chromatography  or frozen until needed. 
No significant alteration of lipid content was observed in cells stored for up to 
6 mo at -70"C. Stocks were usually prepared as pellets of 5 x  10  7 cells; 0.2 ml 
containing  -10 mg protein.  Radiolabeled lipids were prepared  from subcon- 
fluent cultures  of cells grown in normal medium containing  25 vCi/ml 14C- 
acetic acid (sodium salt; New England Nuclear, Boston, MA). Cells were labeled 
for 24 h to insure the labeling of all cellular lipids without substantial entry of 
~4C  into  other  pathways;  >85%  of all  counts were  incorporated  as  lipid 
components. Extraction was carried out in combination  with unlabeled "car- 
tier" cells to improve recovery, which was usually >80%. 
Lipid Extraction 
Lipid analysis was carried out in acid-washed glassware fitted with either 
ground glass stoppers or teflon-lined  screw-caps (Kontes Co., Vineland,  N  J). 
Solvents were all reagent grade (Fisher Scientific Co., Fairlawn, NJ) and were 
redistilled before use. Samples were kept under nitrogen gas and in the dark 
wherever practical. Phospholipid  standards  were obtained  from Avanti Polar 
Lipids,  lnc.,  Birmingham,  AL;  fatty  acids  and  methyl  esters  of fatty  acids 
(FAMEs) from Nu-chek Prep, Inc., Elysian, MN, and other neutral lipids from 
Supelco, inc., Bellefonte, PA, or Sigma Chemical Co., St. Louis, MO. General 
chromatographic  procedures were adapted from Kales (36). 
Cells were extracted by a modification  of the standard  procedure  of Foleh 
et at. (18). Ceil pellets were suspended  in 2  ml of methanol  with a  pasteur 
pipette  and allowed to stand for -10  min with occasional  mixing.  2 ml of 
chloroform  was added, the tube vortexed, and allowed to sit for a further  10 
rain.  A second  aliquot  of 2  ml  CHCI~ was then  added,  bringing  the  final 
solution  to  a  ratio  of 2:1  CHCI~/MeOH.  Cellular  debris  was  pelleted  by 
centrifugation; the solvent containing extracted lipids was transferred to a fresh 
tube and brought to a total volume of 6 ml with CHCI3/MeOH (2:1). To this 
mixture  we added  1.2  ml of 0.1  M KCI in H20,  and the tube was ~ortexed 
vigorously several times. After a brief centrifugation,  the aqueous phase was 
removed and polar glycolipids (gangliosides) prepared by dialysis against three 
changes of 3,000 ml H20 over the course of 24 h, followed by lyophilization. 
The organic phase from the Folch extraction, containing phospholipids, neutral 
Thin Layer Chromatography 
Thin layer chromatography  plates were obtained precoated (@25-mm silica 
gel 60 without  fluorescence indicator,  on 20 x  20 cm glass plates; E. Merck, 
Cincinatti, OH). Plates were prewashed in solvent system A (see below) in one 
or two directions (depending on the experimental  protocol)  and activated at 
120°C for 1 h immediately prior to use. Samples were dissolved in a minimal 
volume of 2:1 CHCI3/MeOH and spotted (under a gentle flow of nitrogen gas) 
across a horizontal band at a distance of 1.5 cm from the bottom of the plate. 
Chromatography was carried out at room temperature in tanks lined with filter 
paper and equilibrated for at least 2 h prior to development.  Solvent schedules 
used were as follows and are referenced by letter in the text. 
ONE-DIMENSIONAL  SEPARATIONS:  (A)  Hexanes/ethyl  ether/acetic 
acid; 80:20:2; run for  18  cm. (B) Hexanes/ethyl  ether; 95:5; run for 18 cm, 
dried  under N2  and  rerun in  the  same direction.  (C)  CHCI3/MeOH/HzO; 
100:42:6; run for 11  cm, dried under N2, and redeveloped (in same direction 
for 18 cm) according to solvent schedule A. (D) CHCI3/MeOH/0.2%  CaCI2 in 
H20; 60:40:9; run to 18 cm. 
TWO-DIMENSIONAL  SEPARATIONS:  Plates were run  17  cm in first 
solvent system, then dried under N2, turned 90  ° counterclockwise, and run 17 
cm  in  second  solvent  system.  (E)  (First  dimension)  CHC13/MeOH/30% 
NH3OH;  65:25:5.  (Second  dimension)  CHCI3/MeOH/H20/CH3COCH3/ 
CH3COOH; 30:10:5:40:10. (F) (First dimension) CHCIa/MeOH/30%  NH3OH; 
95:5:0.5.  (Second  dimension)  CHCI3/MeOH/H20/CH3COCH3/CH3COOH; 
80:2.5:2:15:2.5. (G) (First dimension) Hexanes/ethyl ether/acetic acid; 80:20:2. 
(Second dimension) CHCIa/MeOH/30%  NH3OH; 95:5:0.5. 
Plates were air dried and stained by exposure to iodine  vapor or sprayed 
with various specific detection  reagents as described in the text. Some plates 
were also sprayed with a strong oxidizing solution, charred by brief heating at 
120°C and  analyzed  by  scanning  densitomctry.  All  chromatograms in  this 
communication were stained with iodine vapor (except for autoradiograms). 
Permanent records were made on 4 × 5 inch negatives or as direct photocopies. 
Radiolabeled chromatography plates were autoradiographed directly or sprayed 
with a 20% solution of 2,5-diphenyloxazole in ethyl ether or EN3HANCE spray 
(New England Nuclear). Autoradiography  was performed  using Fuji  RX or 
Kodak X-Omat AR X-ray film. 
For preparative thin layer chromatography,  compounds were run in parallel 
with reference lanes containing known cellular lipids or lipid standards. Plates 
were dried  under N2, scored and broken,  and the reference lanes stained to 
determine the location of specific compounds. Adjacent areas on the unstained 
plate were lightly moistened with water, scraped, dried under N2, and the lipid 
eluted from the sorbent with several washes of 1:1 CHCI3/MeOH. Aliquots of 
the eluted lipid were always checked for purity by thin layer chromatography. 
Liquid Column Chromatography 
For separation of whole cell lipid extracts into phospholipid, glycolipid, and 
neutral  lipid fractions, columns were prepared  as follows.  1 g of 325  mesh 
silieic acid (Bio-Sil HA; Bio-Rad Laboratories, Richmond,  CA) was washed in 
two changes of methanol, dried, and activated for several hours at 120°C. The 
silicic acid was slurried in CHCI3 and packed on top of glass wool in a 4-mm 
(inside diameter) thick-walled glass chromatographic  column equipped with a 
solvent reservoir and pressure couple (Kontes Co.). The column was washed 
with 50 ml CHCI3 and the sample applied in a  minimal  volume  of CHCI~. 
Three fractions were eluted: neutral lipids (including monoglyceride, diglycer- 
ide, triglyceride, cholesterol, free fatty acid, alkyldiacylglycerol, and eholesteryl 
ester of fatty acid) were removed by three successive 5-ml aliquols of chloro- 
form; neutral  glycolipids were eluted  in three  15-ml washes of acetone; and 
phospholipids were eluted with three 5-ml aliquots of methanol. Solvents were 
forced through  the fine mesh silica under nitrogen supplied at 30 psi. Each 
fraction was found to be >98% pure by two-dimensional thin layer chromatog- 
raphy. 
Hydrolysis and Detection of Plasmalogen 
(AIk- 1-enyl) Linkages 
A modification  of previously  published  procedures  (31, 62) was used to 
detect neutral and polar plasmalogen (alk-l-enyl  lipids) on a single thin layer 
plate. Each sample was spotted on a separate plate in a single l-cm lane spotted 
I cm from the left edge of the plate and separated according to the two-step 
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to 12 N HC1 at 40"C for 1-4 min at a distance of 4 cm while the remainder of 
the plate (all but the left-most 3.5 era) was masked to prevent exposure to acid. 
Acid was removed by extensive evaporation under Nz, and the plate rotated 
counterclockwise  for development in the second dimension according to chro- 
matography schedule A. Aliquots of unhydrolyzed lipid and synthetic octade- 
cenal were  run  in  parallel to  allow identification of the aldehyde products 
released by hydrolysis of the alk-l-enyl  double bond. 
Methanolysis and Fatty Acid Analysis 
Samples were  mixed in a  15-ml round bottom tube with  1.5 ml of a 9:1 
mixture of methanol/acetyl  chloride (prepared on ice) and 0.5 ml of dry toluene 
to aid in solubilization  of neutral lipids (43). Tubes were gassed with nitrogen, 
tightly sealed using teflon-lined screw-caps and heated overnight at 80"C in a 
block heater.  The next day,  samples were cooled and the reaction quenched 
with I ml of H20.  Lipids were extracted with two washes of 3 ml hexane each, 
and the aqueous phase discarded.  The hexane fraction was dried completely by 
addition of a small amount of4:l NaSO,/NaHCO~,  vortexed,  filtered through 
glass wool and dried under nitrogen.  Saponified  lipids were examined by thin 
layer chromatography (Fig. 6 only) or resuspended  in a small volume of CS2 
for gas-liquid chromatography. 
Gas-liquid  chromatography  was carried out on a Hewlett-Packard  HP7620A 
gas chromatograph with a  model 3380S  integrator. The FAME products of 
methanolysis  were separated  on a 6-ft x  2-mm glass column packed with 10% 
SP-2330 on 100/120 mesh Chromosorb W-AW (Supelco, Inc.). Nitrogen carrier 
flow was maintained at  1.8  psi, and the injection port and flame ionization 
detector set at 250°C. Oven temperature was programmed to hold 150*C for 2 
min following injection, rise at the rate of 4*C/min to 200"C and hold that 
temperature for 30 rain until all FAMEs were detected.  Identical results were 
obtained when FAMEs were prepared by methanolysis  of unextracted cells or 
of CHC13/MeOH  extracts;  no change was observed  when FAME products of 
the saponification reaction were purified by preparative thin layer chromatog- 
raphy before injection. 
RESULTS 
Fusion-resistant Cell Lines 
When  the parental  cell  line,  Clone  1  D,  is treated with a 
standard PEG-fusion protocol, <5% of the cells remain un- 
fused (54, 59; Fig. 1A). Most cells are fused into giant syncytia, 
containing hundreds or even thousands of nuclei. Repeated 
rounds  of  PEG  treatment  resulted  in  progressively  more 
highly PEG-resistant cells,  as shown in  Fig.  1 for cell  lines 
Clone  ID, F4,  1=8, F~6, and F40. Treatment of F4o cells with 
PEG produced -20% fusion (Fig.  1  E), and those cells which 
did fuse formed smaller multinucleates than found in fused 
monolayers of Clone  1D.  The I=4, Fs,  and  Fir cell  lines are 
intermediate in their response to PEG, as shown in Fig.  1, B- 
D. We have previously analyzed several subclones from cell 
lines with varying degrees of fusion resistance, and found that 
these cell lines are homogeneous with respect to PEG sensitiv- 
ity (reference 59, and similar unpublished experiments). The 
fusion-resistant phenotype is stable at each level of selection 
(59). These results indicate that the PEG-resistant phenotype 
is gradually acquired by the  population  as a  whole,  rather 
than being produced by enrichment of  the population with de- 
scendants from a mutant, PEG-resistant cell which was pres- 
ent in the original culture. Since isolation, the highly fusion- 
resistant cell line F4o has been maintained for over 250 gen- 
erations in continuous culture with no effect on its sensitivity 
to PEG-induced fusion. For the biochemical studies presented 
below, we have primarily used cell lines Clone  1D,  F=6,  and 
F4o, which exhibit ~100,  50,  and  20%  fusion, respectively, 
following PEG treatment. 
Analysis of Lipid Class Composition 
To investigate specific cellular properties correlated with 
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differences in response to PEG, we analyzed the genetic and 
biochemical characteristics of these ceils. Fig. 2 illustrates the 
lipid class composition observed when Clone 1D, F~6, and F4o 
cells were extracted with organic solvents and separated by 
one-dimensional thin layer chromatography according to sol- 
vent schedule C. In Fig. 2A, extracts of Clone 1D (lane 2) and 
F4o (lane  5) were run  in  parallel with  lipid standards.  The 
direction of solvent flow was from bottom to top, with the 
more polar lipids nearer the bottom. Major cellular lipids in 
the lower third of the plate correspond, in order of increasing 
mobility, to various phospholipids: sphingomyelin (doublet), 
phosphatidyl choline/phosphatidyl serine/phosphatidyl  ino- 
sitol/phosphatidic acid (not completely resolved from each 
other), cardiolipin,  and phosphatidylethanolamine.  Most of 
the minor bands visible in the lower two-thirds of the chro- 
matogram (particularly  between  cardiolipin  and  phospha- 
tidylethanolamine,  and  above the  latter)  are  neutral  glyco- 
lipids, confirmed by reaction with an a-naphthol spray reagent 
(not shown). 
In the  upper third  of the chromatogram various neutral 
lipids are separated, producing a  dense band of cholesterol 
followed by more hydrophobic  compounds,  including  free 
fatty acids, diglycerides,  triglycerides, alkyldiacylglycerols, and 
cholesteryl esters, in order of decreasing polarity. Most neutral 
lipids were considerably more pronounced in F4o cells than 
in Clone 1D, particularly the triglycerides (single arrows) and 
alkyldiacylglycerols (double arrows). Further characterization 
of alkyldiacylglycerol, an  unusual  ether-linked glyceride, is 
provided below. Quantitative densitometry of charred chro- 
matograms indicated that triglyceride content is elevated ap- 
proximately sixfold in F4o over Clone I D, and that the ether 
lipid content is increased  ~36-fold in  F4o (average of three 
experiments). In these PEG-resistant cells, GE may represent 
as much as 20% of  the neutral lipid, second only to cholesterol 
in prominence. Substantial levels of fatty alcohols, a metabolic 
precursor of the ether-linked lipids (24, 84), were also found 
in F4o cells (not clearly visible in this chromatogram). Mon- 
oglyceride and,  to  a  lesser extent,  diglyceride content  was 
usually slightly  increased  in  F,o  relative to Clone  l D.  The 
content of free fatty acids found in these ceils was somewhat 
variable, with free fatty acid content usually slightly  elevated 
in Clone  ID over F4o. Cholesteryl esters are less common in 
most preparations of Clone 1D than in F4o, but differences in 
cholesterol level were not consistently observed. 
One of the advantages of a graded series of cell lines is the 
ability to examine not only fusible and fusion-resistant cells, 
but  also  a  wide  range  of intermediate  cell  lines.  Fig.  2B 
demonstrates that the differences in neutral lipid composition 
observed between Clone 1D and F4o were acquired gradually 
throughout  the  selection  procedure.  Both  triglyceride  and 
ether lipid content increase between Clone 1D and the mod- 
erately fusion-resistant cell  line Fl6 (compare lanes  1 and 2 
with lane 3), and rise further in F4o (lanes 4 and 5). As in Fig. 
2A, no differences in polar lipid composition were seen be- 
tween cell lines. This figure also illustrates the reproducibility 
of these results and the stability of the cell lines: the samples 
shown in lanes  1 and 5 were separated from those used in 
lanes 2-4 by ~ 1 yr of continuous culture, and the earlier and 
later cell  stocks were grown in medium supplemented with 
different serum lots.  Nevertheless, the two extracts of Clone 
1D cells (lanes 1 and 2) are virtually indistinguishable from 
each other, and both contain low levels of triglyceride and 
alkyldiacylglycerol, while both F4o cell  extracts (lanes 4 and FIGURE  1  Response of, Clone 1D and fusion-resistant cell lines to PEG. Confluent cultures of Clone  1D and cell lines selected 
from Clone 1D by 4, 8,  16, or 40 cycles of PEG treatment (designated F4, Fs, F16, and F40, respectively) were fused with 50% PEG 
1000. Fields shown were selected at random. (A) Clone 1  D; (B) F4; (C) Fs; (D) F~6; and (E) F4o. 
Roos ^NO CHOPPIN  Lipid Composition of Fusion-resistant  Cells  1581 FIGURE 2  Lipid class composition of Clone 1D, F,6, and F4o cells. Each lane contains lipids extracted from  10  z cells (A and B) or 
25,000 cpm 14C derived from  labeled acetate  (C). All thin layer chromatograms  were run according to solvent schedule C, and 
exposed to iodine vapor (A and B) or autoradiography film (C). Direction of solvent flow is from bottom to top. (A) Lipid extracts 
of Clone 1D and F40 cells are shown in lanes 2 and 5, respectively. Other lanes contain mixtures of standards at 15 tzg/compound 
(30 ~g for cholesterol  [Ch]); these are  as follows: (lane  I) (from  bottom  to top)  lysophosphatidyl choline (LPC); phosphatidyl 
inositol (PI); cardiolipin (CL); monoglyceride  (MG); fatty alcohol (FAOH); cholesteryl ester  of fatty acid  (CE); and long chain 
hydrocarbon (HC; merged with CE). (Lane 3) Sphingomyelin (SM; doublet); phosphatidyl choline (PC); phosphatidylethanolamine 
(PE); MG; Ch; FAME; CE; and HC. (Lane 4) LPC; phosphatidyl serine (PS); CL; MG; free fatty acid; triglyceride (TG); and HC. (Lane 
6) SM; phosphatidic acid (PA); PE; diglyceride (DG); TG; CE; and HC. TG is indicated by single arrows; double arrows denote the 
unusual ether-linked lipid discussed  in the text (alkyldiacylglycerol [GE]). (B) Correlation of ether lipid with fusion-resistant  cells. 
(Lanes 1 and 2) Clone 1D. (Lane 3) F16. (Lanes 4 and 5) F40. Cells extracted for lanes 1 and 5 were grown in one serum lot, and 
were separated  by nearly 1 yr of continuous culture from cells in lanes 2-4, which were grown in a different serum  lot. The 
presence  of GE (double arrows) was correlated with fusion resistance, but not with age in culture or growth medium used. the 
ether lipid and triglyceride content of F16 is intermediate between Clone 1D and F4o. (C) Metabolic labeling of Clone 1  D, F16,  and 
F4o lipids. Cells were incubated for 24 h in the presence of ~4C-labeled  acetate, followed by extraction, thin layer chromatography, 
and autoradiography. Single and double arrows  indicate the position of TG and GE, respectively. {Lane 1) Clone 1D. (Lane 2) F16. 
(Lane 3) F4o. 
5)  contain  elevated  levels  of triglyceride and  alkyldiacyl- 
glycerol. 
Fig. 2C illustrates the metabolic labeling of Clone 1D, F~6, 
and  F4o cells  with  ~4C-acetate. Labeling of polar lipids was 
similar in Clone 1D, Ft6, and F4o (lower portion of lanes 1, 2, 
and 3, respectively), but differences in neutral lipid composi- 
tion that were observed in unlabeled cells were also seen with 
the radioactive lipids. Indeed, the enhancement of  triglyceride 
and  alkyldiacylglycerol production is  somewhat more pro- 
nounced in the metabolically labeled cells. 
To examine lipid class composition in greater detail, a series 
of two-dimensional thin  layer chromatographic separations 
was used.  Fig.  3 shows the analysis of Clone  1D (A-C) and 
F4o (D-F) using three different solvent schedules designed to 
separate  different groups  of compounds.  For each  solvent 
schedule used, a composite drawing has been provided (G-/), 
with the lipid species numbered as described in the legend. In 
the left panels are shown separations of phospholipids and 
neutral glycolipids.  Despite clear separation of a wide variety 
of phospholipid  and  neutral  glycolipid  species  (Fig.  3G), 
neither  qualitative  nor  quantitative  differences have  been 
detected between  Clone  1D  and  F4o  (compare A  and  D). 
Phospholipids are numbered 1-8; glycolipids are separated 
along an irregular concave-up curve of doublets and singlets 
which have not been numbered (identity determined by stain- 
ing with specific spray reagents and pattern of elution from a 
silicic acid column). The chromatograms reproduced in the 
center panels (Fig. 3, B and E) separated lipids of  intermediate 
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polarity, including monoglycerides, cholesterol, and free fatty 
acids,  as indicated in Fig.  3H. Again,  no substantive differ- 
ences were detected between  Clone  1D  and  F4o cells  (the 
increase in monoglyceride  in F4o cells is not always as apparent 
as here; cf. Fig.  2A).  Neutral lipid separations are shown in 
the right panels (Fig.  3, C, F, and/). As already seen in the 
one-dimensional separations, triglyceride (single arrows) and 
alkyldiacylglycerol (double arrows) were greatly elevated in 
F4o (Fig. 3 F) over Clone 1D (Fig. 3 C). 
The highly polar gangliosides  partition into the aqueous 
phase during Folch extraction, and hence are not visible in 
the  chromatograms  shown  above.  Because  glycolipids are 
primarily found in plasma membranes and have been impli- 
cated in various membrane interactions (27), ganglioside com- 
position was examined in several of the fusion-resistant mu- 
tants. Fig.  4  shows  the separation of the polar gangliosides 
purified (as described in Materials and Methods) from radio- 
labeled Clone  ID, F,6, and F4o extracts (lanes 1-3) and an 
unlabeled mixture of Clone 1D and F,o gangliosides  (lane 4). 
This chromatogram suggests that increased resistance to PEG- 
induced fusion is correlated with decreased ganglioside  con- 
tent. The significance of these results is unclear, however, as 
so little ganglioside  is present in any of the cell lines under 
study. Polar glycolipids account for <0.5% of the t4C-acetate 
label in Clone 1D, and even less in Fl6 and F4o cells (0.25% 
and 0.2%, respectively). Neutral glycolipid composition var- 
ied considerably from experiment to experiment, and appears 
to be strongly affected by cell density (not shown). No repro- FIGURE 3  Two-dimensional  analysis of lipid composition. Lipid extracts of Clone 1D cells (A-C) or F4o cells (D-F) were subjected 
to two-dimensional thin layer chromatography according to solvent schedule  E (A and D) to separate polar lipids, schedule  F (B 
and £) to separate lipids of intermediate polarity, or schedule G (C and F) to separate neutral lipid classes. Lipids from 3 x  10  7 
cells were spotted at the lower left corner of each plate, and in all panels the direction of solvent flow was from bottom to top in 
the first solvent mixture and from left to right in the second dimension. G-I are composite drawings representing spots detected 
in the corresponding chromatograms.  Numbered spots have been identified as follows: 0, origin; 7, LPC; 2, SM; 3, PC; 4, PS; 5, 
PI; 6, PA; 7, PE; 8, CL; 9, MG; 10, Ch;  11, free fatty acid; 12, 1,2-DG;  13, 1,3-DG;  14, unknown; 15, 1-alkyl,2-acylglycerol?; 16, 1- 
alkyl,3-acylglycerol?;  17, TG;  18, GE; 19, CE. Most of the unlabeled spots which are separated along a gentle convex-up curve in 
panels A and D are neutral glycolipids. Clone 1D and F4o lipids are similar in all respects save GE (double arrows) and TG (single 
arrows). Abbreviations are as in Fig. 2. 
ducible correlation could be established between neutral gly- 
colipids and fusion response, however, suggesting that these 
compounds do not play a direct role in PEG-induced fusion. 
Characterization of the Ether Lipid That Is 
Enriched in Fusion-resistant  Cells 
Alkyldiacylglycerol,  the  neutral  lipid  compound  whose 
presence  is  most  highly  correlated  with  the  PEG  fusion- 
resistant phenotype, is an unusual one, intermediate in polar- 
ity between triglyceride and  cholesteryl ester in  the  solvent 
systems thus far illustrated (double arrows in Figs.  2 and 3). 
We were first alerted to the presence of this lipid by chance, 
due to the development of a thin layer chromatography plate 
in a solvent in which the polarity had changed due to absorp- 
tion of excessive moisture from the air. The then-unidentified 
Roos AND CHOPPIN Lipid  Composition  of Fusion-resistant  Cells  1  $83 lipid was characterized by peculiar mobility, moving differ- 
ently with respect to other neutral lipids depending on the 
solvent  system  used,  a  phenomenon illustrated  in  Fig.  5. 
FIGURE 4  Gangliosides of Clone 1  D, F16,  and F40 cells. The aqueous 
(upper) phases from Folch extractions of [14C]acetate-labeled (lanes 
1-3) or unlabeled (lane 4) cells were extensively dialyzed against 
water,  lyophilized, and  chromatographed according  to  solvent 
schedule D.  Extracts from  3 x  107 labeled cells were spotted in 
lanes  1-3 (Clone 1D,  F16, and  F4o cells,  respectively)  and fluoro- 
graphed  for 61  d.  Lane 4 contains  a mixture of 2 x  108 Clone 1D 
and 2 ×  108 F4o cells, and was developed by exposure to iodine 
vapor.  Lane 5 contains  bovine brain gangliosides. 
Panels A and B show reproductions of identically spotted thin 
layer plates which were developed in different solvents. Lipids 
extracted from Clone 1D are shown in lanes 2, while F4o lipids 
are in lanes 3. The ether lipid (indicated by a star) was clearly 
present at high concentration in F4o, but was undetectable in 
Clone  ID cells.  Lanes 1 and 4  contain mixtures of neutral 
lipid standards.  The only relevant difference between these 
standard mixtures is the presence of FAME in lanes 1 (meth- 
ylolein; indicated by single arrows) and a synthetic ether lipid 
(l-O-hexadecyl,  2,3  dipalmityl-glycerol; double  arrows)  in 
lanes 4. In Fig. 5A, the ether lipid ran very rapidly, migrating 
ahead of FAME, and considerably faster than triglyceride. In 
a different solvent system, however, the synthetic ether lipid 
ran far more slowly than FAME and only slightly faster than 
triglyceride (Fig.  5 B).  This pattern of migration in different 
solvents is characteristic of alkyldiacylglycerols  (69), an inter- 
esting minor lipid species synthesized by the replacement of 
the acyl chain of acyl-dihydroxyacetone phosphate with an 
alkyl group derived from free fatty alcohols (24, 84). In each 
solvent system, the unusual lipid associated with F4o cells co- 
migrates with the synthetic alkyldiacylglycerol, and is clearly 
distinct from triglyceride, FAME,  cholesteryl ester of fatty 
acid, and other neutral lipids. 
To prove the identity of the unusual Fao lipid,  this com- 
pound  and  the  putative triglyceride band  was  isolated by 
preparative thin layer chromatography and subjected to meth- 
anolysis.  Extensive acid hydrolysis in the presence of metha- 
nol would be expected to release any esterified fatty acid (acyl) 
chains as FAME while leaving ether-linked (alkyl) fatty acids 
attached to the glycerol backbone. Fig. 6A  shows  products 
from the methanolysis of synthetic standards. Lipid standards 
in  lanes  1,  4,  and  5  demonstrate  the mobility of various 
FIGURE 5  Thin  layer chromato- 
graphic  mobility of the  unusual 
lipid found in F4o cells.  Lipid  ex- 
tracts from Clone 1  D and F4o cells 
were chromatographed in parallel 
with authentic standards. A and B 
are identical except for being run 
in  different  solvent  systems  (A, 
solvent  schedule  A;  B,  solvent 
schedule  B).  (Lanes  I)  Ch;  free 
fatty acid; TG; FAME; and CE (in 
order of decreasing polarity, from 
top  to  bottom).  (Lanes 2)  Lipid 
extract from 1.5 ×  107 Clone 1D 
cells. (Lanes 3) Lipid extract from 
1.5 ×  107 F40 cells. (Lanes 4) Ch; 
free fatty  acid;  TG;  GE; CE; and 
HC. The synthetic  ether lipid (1- 
O-hexadecyl, 2,3 dipalmityl glyc- 
erol, indicated by double arrow- 
heads) migrates  particularly  rap- 
idly in A and particularly slowly in 
B  relative  to  other  standards 
(compare  especially with  FAME, 
indicated  by  single  arrows).  In 
both  panels,  however, the  unu- 
sual lipid found in F4o (*) co-mi- 
grates with GE. Abbreviations are 
as in Fig. 2. 
1584  THE  JOURNAL OF  CELL BIOLOGY - VOLUME  101, 1985 F}GUR[  6  Methanolysis of the ether lipid. Synthetic lipid standards or experimental samples prepared by preparative thin layer 
chromatography  of  F4o cell  lipid extracts  were  refluxed  in methanolic  HCl and  saponified  products  extracted  in  hexane for 
chromatography in parallel with unreacted lipid standards. Comparison of the methanolysis  products of known compounds in A 
(lanes 2 and 3) with F4o-derived lipids run in the same solvent system (B, lanes 7 and 8) confirms the identity of these F4o lipids as 
GE and  TG.  (A) Methanolysis of synthetic tripalmitylglycerol (TG) and  1-O-hexadecyl, 2,3-dipalmitylglycerol (GE). Thin layer 
chromatography was run according to solvent schedule A. (Lane  1) Unreacted  mixture of Ch, free fatty acid,  TG, GE, and CE 
(from bottom to top in order of decreasing  polarity). (Lane 2) Methanolyzed GE, producing FAME (upper spot) and monoalkyl- 
glycerol (MGE)  (near the origin). (Lane 3)  Methanolyzed TG, producing FAME only. The glycerol backbone  is not soluble in 
hexanes,  and hence was not extracted from  the saponification mixture. (Lane 4) Untreated Ch, free fatty acid,  TG,  FAME, and 
CE. This lane differs from lane  1 only in the substitution of FAME for GE. (Lane 5) Unsaponified GE; when juxtaposed with FAME 
in lane 4,  this compound  is clearly distinct. (B and C) Methanolysis of putative GE and TG  bands  isolated  from  ~4C-acetate- 
labeled F4o cells. B and C differ only in the solvent system for separation:  B was run in system A, and C according to schedule C. 
(Lanes 6 and  10) Unreacted  lipid extracts  from  F40 ceils.  Double and single arrowheads indicate, respectively, the putative GE 
and TG bands which were eluted for saponification. (Lanes 7 and  11) Methanolysis products of the putative GE band  purified 
from F4o cells. Two spots are visible, corresponding to FAME (upper spot; compare lane 11 with the FAME standard  in lane  13) 
and  MGE  (lower  spot;  compare  lane  7  with  the  synthetic  standard  in  lane  9).  Relative  activity  of  these  compounds  was 
approximately 2:1, as expected for GE. (Lanes 8 and  /2) Methanolysis of the putative TG band from  F40. Only FAME was found 
in this sample, indicating that the original sample contained acyl, but not alkyl linkages. Abbreviations are as in Fig. 2. 
compounds  in  this  system;  alkyldiacylglycerol was  cleady 
distinguishable from other neutral lipids (including FAME) 
as shown by comparison of lanes 4 and 5. Lipids produced 
by the methanolysis of  alkyldiacylglycerol  and triglyceride are 
shown in lanes 2 and 3, respectively. The only product of the 
triglyceride reaction was FAME (the glycerol backbone does 
not extract from the reaction mixture into organic solvent). 
Methanolysis of alkyldiacylglycerol, however, produced both 
acyl chains and  l-O-alkylglycerol, visible  slightly above the 
origin in lane 2. 
Fig. 6, B and C, illustrates the same procedure applied to 
lipids extracted from  F,o. These two  chromatograms were 
spotted with  identical samples  but run  in  different solvent 
systems.  In  lanes  6  and  10,  unfractionated  F4o  lipids  are 
shown,  indicating the  mobility of the  putative  ether lipid 
(double arrows) and triglyceride (single arrows) in these sol- 
vent systems. These bands were extracted, methanolyzed, and 
run  in  lanes  7  and  11  (alkyldiacylglycerol) or  8  and  12 
(triglyceride).  Lipid standards were run in lanes 9 and 13. In 
lanes  8  and  12,  only  FAME  was  found,  confirming  the 
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the  ether  lipid  was  saponified,  however, both  monoalkyl- 
glycerol and FAME were released (most clearly seen in lanes 
7 and  11,  respectively). Removal of these spots and quanti- 
tation in a scintillation counter demonstrated a 2:1  ratio of 
fatty acid chains between the ether lipid--derived  FAME and 
monoalkylglycerol, confirming this  unusual  lipid  from F4o 
cells as alkyldiacylglycerol. The ratio of radioactivity released 
as FAME by saponification of triglyceride and alkyldiacylgly- 
cerol was ~3:2, as predicted. Similar analyses of other neutral 
lipid bands (not shown) demonstrated the presence of alkyl- 
diacylglycerol  and small amounts of monoalkylglycerol  in F4o. 
No di- or trialkylglycerols  were detected. 
The neutral ether lipid found in F4o cells is distinct from 
plasmalogens (lipids which contain an alk-1-enyl-linked hy- 
drocarbon chain), based both on thin layer chromatographic 
mobility and susceptibility to acid hydrolysis. As the plasmal- 
ogens  are  the  most  prominent  ether-linked  lipid  in  most 
animal tissues (32), it was of interest to examine plasmalogen 
content in Clone 1D and F4o cells. Because of the proximity 
of  the double bond to the ether-oxygen  in plasmalogens, these 
compounds are very sensitive to acid hydrolysis, liberating 
the hydrocarbon chain as an aldehyde (3, 62). Taking advan- 
tage  of this  fact, a  single-plate  chromatographic procedure 
was used to simultaneously allow distinction of alkyl and alk- 
l-enyl linkages in both neutral and phospholipids. 
In Fig.  7,  lipids extracted from Clone  1D (A) or F4o (B) 
were separated in the vertical dimension, briefly exposed to 
acid fumes, and the partial hydrolysis products separated from 
left to right in parallel with a fresh aliquot of unhydrolyzed 
lipid (at the top of the plate).  The migration of an aldehyde 
standard is indicated at the bottom of the chromatograms by 
large arrows. Substantial amounts of ethanolamine plasmal- 
ogen were cleaved by the action of HC1 fumes, as indicated 
FIGURE 7  Plasmalogen content of Clone 1  D and F40 cells. Lipid extracts from 5 x  10  7  Clone I D or F4o cells (A and B, respectively) 
were separated according to solvent schedule C, exposed to HCI fumes briefly to hydrolyze the alk-1  -enyl bonds of plasmalogens, 
and separated in the second dimension (from left to right) in solvent system A, in parallel with unhydrolyzed sample at the top 
of the plate. Hydrolysis of the plasmalogen alk-l-enyl linkages released aldehydes from PE (marked by the square) but not from 
the neutral ether lipid (double arrowhead),  demonstrating that the ether-linked lipid in F~ is not a neutral plasmalogen. The 
arrow at the bottom of the figure indicates the migration of an aldehyde standard; the expected position for aldehydes released 
from neutral plasmalogens is marked with a circle.  In this  particular  experiment, lipids separated in the first  dimension were 
exposed to acid fumes  for approximately twice as long as necessary to detect aldehyde release to ensure that plasmalogen 
hydrolysis was complete in the neutral lipids, which are somewhat less accessible due to their tendency to form lipid droplets 
within the chromatogram sorbent. As a result of this prolonged hydrolysis, some fatty acids were also released from PE and PC. 
Several compounds are identified at left and in the unhydrolyzed sample at top. Increased FAOH content can be seen in F40 cells 
compared with Clone 1  D (small arrows). Abbreviations are as in Fig. 2. 
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content were detected between Clone 1D and F4o lipids. Low 
levels of choline plasmalogens were also detected in both cell 
lines.  No aldehydes were released from the ether lipid found 
in  F4o cells  (open circle), confirming this compound as an 
alkyl, rather than alk- 1-enyl, lipid. These chromatograms also 
allow clear visualization of fatty alcohols (small arrows), dem- 
onstrating considerably higher concentrations of this impor- 
tant ether lipid precursor in F4o cells than were found in Clone 
ID. 
TABLE II.  Fatty  Acid Composition of Lipid Fractions* 
Whole cells  Phospholipids  Neutral lipids 
Cell line  S  M  P  S  M  P  S  M  P 
Clone 1D  32  42  24  32  36  31  52  33  14 
F16  38  44  16  33  38  24  45  41  12 
F4o  40  44  12  35  43  20  54  34  12 
* Percent of fatty acyl chains present as saturated (S), monounsaturated  (M), 
or polyunsaturated (P) in whole cells or phospholipid or neutral lipid column 
fractions from liquid chromatography  on silicic acid. 
Composition of Fatty Acid Chains 
Biologically relevant fatty acids are found with diverse chain 
length and degree of saturation. As a  major component of 
cell membranes, they may exert considerable influence on 
membrane interactions (35, 73, 75). Quantitative analysis of 
the fatty acid composition of Clone  I D  and several of the 
fusion-resistant cell lines is shown in Table I. Individual fatty 
acids are compiled into saturated, monounsaturated, or poly- 
unsaturated classes at the top of the table. The most striking 
variation observed was the gradual increase of saturated fatty 
acids in the more fusion-resistant cells, and the concomitant 
loss of polyunsaturated fatty acids.  The ratio of saturated to 
polyunsaturated fatty acids (S/P ratio) increased from 1:1 in 
the  parental  cells  to 4:1  in  the  F4o mutants.  Cell  lines of 
intermediate resistance to PEG treatment exhibited interme- 
diate S/P ratios: 2.4 for F4, 2.9 for Fs, and 3.4 for F~6. 
In the course of the selection of our most highly fusion- 
resistant cell line (F4o), 55%  of the arachidonic acid (20:4) 
found in Clone  1D was lost. In parallel,  the content of the 
most common saturated fatty acid, stearic acid (18:0),  was 
TABLE  I.  Fatty  Acid Composition  of Clone 1D Cells and Cell Lines 
with Increased Resistance to Polyethylene Glycol-induced Fusion* 
Clone 
I D  F4  Fa  FIo  F~ 
Class* 
Saturated  29  38  41  42  43 
Monoenoic  39  45  44  43  44 
Polyenoic  29  15  14  12  11 
SIP RATIO  1.00  2.43  2.88  3.35  4.04 
Individual Acids 
14:0  0.3  0.5  0.6  0.7  1.0 
14:1  0.8  1.1  1.3  1.0  1.2 
16:0  14.4  17.0  18.1  18.2  19.4 
16:1  5.8  4.2  4.3  4.2  4.4 
18:0  12.4  17.4  19.1  19.7  19.7 
18:1  31.3  38.3  37.2  36.9  37.6 
18:2  4.5  3.5  2.5  2.6  2.5 
20:0  0.3  0.4  0.4  0.5  0.4 
20:1  0.7  1.1  1.0  1.0  1.1 
20:2  0.5  0.4  0.1  0.1  0.1 
20:4  10.1  4.8  5.4  4.9  4.5 
22:0  0.9  0.6  0.7  1.0  0.8 
22:4  4.3  2.2  2.7  2.0  1.8 
22:5  3.2  1.1  0.7  1.0  0.5 
22:6  4.6  1.9  2.1  1.9  1.3 
24:0  0.4  1.5  1.7  1.8  1.9 
Others  °  5.4  4.2  2.1  2.6  1.9 
* Results are presented as the percentage of total fatty acid chains. Average 
of five experiments. 
* Compilations  by class do not total  100% because of unidentified lipids. 
i "Others" includes both unidentified and minor identified species. 
increased by  59%.  There did  not  seem  to  be  any  strong 
preference for loss of specific polyunsaturates or acquisition 
of any particular species  of saturated fatty acid.  The most 
striking change was the prominence of a rare saturated fatty 
acid (lignoceric acid, 24:0) in F40. This compound was barely 
detectable in Clone  1D,  but increased fivefold in F4o cells, 
accounting for 5% of the whole cell saturated fatty acid (by 
weight). In general, however, across the transition from Clone 
1D to F4o cells, individual acyl chain species varied in parallel 
with other fatty acids of similar saturation. 
To examine the relationship between the elevated neutral 
lipid content and increased saturation of fatty acids, both of 
which  correlate with  increased  resistance  to  PEG-induced 
fusion of these cells, phospholipid and neutral'lipid fractions 
were separated from Clone 1D, F~6, and F4o cells, and these 
fractions were analyzed for fatty acid content. Data from these 
experiments are shown in Table II. As already shown in Table 
I,  the  whole  cell  lipids  of PEG-resistant cell  lines exhibit 
increased saturation and a decreased content of polyunsatu- 
rated fatty acids. However, separated fractions of  neutral lipids 
or phospholipids showed relatively little difference in  fatty 
acid composition between cell lines. The S/P ratio in neutral 
lipids changed from 3.7 to 4.5 and the S/P ratio of phospho- 
lipids  changed  from  1.0  to  1.8. Data  not  presented  here 
indicated nearly constant S/P ratios in glycolipid fatty acid 
chains as well. When individual species of lipids (e.g., phos- 
phatidyl choline or triglyceride) were examined the fatty acid 
chains of these lipids were found to reflect the composition 
of the class (phospholipid or neutral lipid) as a whole (data 
not shown). These results suggest that the increased fatty acid 
saturation and elevated neutral lipid content seen in F4o cells 
are related phenomena: F4o cells derive a large part of their 
high S/P ratio from the elevated levels  of highly saturated 
neutral lipids which they contain. 
DISCUSSION 
Lipid Composition of PEG-resistant Ceils 
To explore the  biochemical mechanisms  by which  cells 
control membrane fusion, we have taken advantage of  a series 
of cell lines that were selected for resistance to the chemical 
fusogen  polyethylene glycol.  The  studies  described  above 
demonstrate a direct correlation between resistance to PEG 
and two aspects of cellular lipid composition: elevated levels 
of alkyldiacylglycerols, and increased saturation of fatty acyl 
chains. The content of these lipid components is correlated 
with fusibility not only at the extremes of highly fusible and 
highly fusion-resistant cells, but also across a wide range of 
intermediate phenotypes. Cells that are partially resistant to 
PEG exhibit an intermediate lipid composition (cf., Fig. 2 B 
and Table I). These differences in lipid composition are highly 
reproducible and independent of cell density. 
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of certain marine organisms and are found at low concentra- 
tion in many other animals, but they are only rarely promi- 
nent in mammalian cells (for review see reference 68). Some 
ionic ether lipids appear to have potent biological activities, 
including platelet-activating factor (5), a choline ether lipid 
with  platelet-activating and anti-hypertensive activities (28, 
49).  Several investigators have demonstrated  a  correlation 
between neutral ether lipids and a wide variety of human and 
animal tumors of different tissues (4, 8,  1  l, 40, 67, 68,  82). 
Tumors induced by the injection of cultured cells also contain 
high levels of alkyldiacylgiycerol (3, 33, 70).  In experiments 
presented elsewhere, the series  of cell lines from Clone  1D 
through F4o, which were selected without any direct reference 
to  tumorigenicity  but  which  possess  gradually  increasing 
amounts of alkyldiacylglycerol,  have provided direct evidence 
for a  correlation between  ether-linked lipids  in  vitro  and 
tumorigenicity in vivo (57). 
The first committed step in the biosynthesis of ether lipids 
is formation of the alkyl bond, which occurs by substitution 
of a fatty alcohol for the esterified fatty acid of acyl-dihydrox- 
yacetone phosphate (24, 84). F4o cells contain increased fatty 
alcohol levels in addition to elevated ether lipid content (Fig. 
7). Recent research has elucidated further molecular details 
of the primary synthetic mechanism (10,  20), although little 
is known of the complex metabolic pathways which may act 
to regulate the  biosynthesis of ether lipid (26).  Ether lipid 
content has been linked to the activities of many enzymes, 
including a specific etherase (71), glycerol-3-phosphate dehy- 
drogenase (24, 33), and other glycolytic enzymes (66). 
In addition to increased ether lipid content, PEG-resistant 
cells contain dramatically elevated fatty acid saturation. Dif- 
ferences in acyl chain composition, particularly chain satu- 
ration, have been studied in many systems (73, 75). There is 
a surprising degree of flexibility in the bulk fatty acid com- 
position of cells, however, and cells in culture will generally 
incorporate any fatty acid supplied, with minimal change in 
physiology (72).  Nevertheless, under certain conditions, al- 
tered fatty acid composition has been associated with several 
biological phenomena, including the activation of membrane 
receptors, membrane-bound enzymes, and transport channels 
(for review see reference 61).  The fluidity of membranes is 
largely a  function of fatty acid composition, and there has 
been considerable speculation that cellular lipids may segre- 
gate into microdomains within membranes (35,  37, 78). Ex- 
periments not presented here have shown similar fatty acid 
saturation to that presented in Table I in Clone  1D and F4o 
cells grown in delipidated medium, suggesting that these cells 
maintain  substantial  control over their membrane  fluidity 
even when grown in serum-containing medium. 
Although the increases in ether lipid content and fatty acid 
saturation in fusion-resistant cells were discovered separately, 
the data from Table II is compiled in Fig.  8 to suggest that 
these phenomena may be related: F4o cells derive their satu- 
rated fatty acids primarily from the large amounts of neutral 
lipids they contain. Neutral lipids usually possess highly sat- 
urated fatty acids (72), and the PEG-resistant cells have very 
high neutral lipid content as compared with the parental line. 
Thus the  high  S/P  ratio  of neutral  lipids  makes  a  major 
contribution to F4o cells, while S/P measurements of Clone 
1D are largey determined by the relatively unsaturated phos- 
pholipids. 
It is important to note that the analyses presented above 
reflect the lipid composition of whole cells. The majority of 
neutral lipid fatty acids are attached to triglycerides in intra- 
cellular lipid droplets, but substantial amounts of  neutral lipid 
fatty acid in F4o cells are also present in ether-linked glycerides. 
The enzymes involved in the biosynthesis of ether lipid are 
microsomal (9,  15), and  the  alkyl-dihydroxyacetone phos- 
phate  synthase is  found in  particularly large  quantities  in 
peroxisomes (25). Cell fractionation studies from several lab- 
oratories have previously demonstrated neutral ether lipids in 
membranous material derived from tumors (70,  83) and in 
the plasma membranes of cultured cells (19, 48, 63). Analysis 
of the membranes of enveloped viruses grown in F4o cells, 
and preliminary analysis of plasma membranes prepared by 
classical cell fractionation techniques has confirmed this ob- 
servation (56). 
Other biochemical associations with PEG resistance may 
also play a role in altered fusion response. In Fig. 4, progressive 
changes in ganglioside  content are visible across this series of 
cell lines. Several arguments lead us to suspect only a minor 
role for these compounds in  fusion,  however.  Very small 
amounts of ganglioside  were found in any of the cell lines 
studied, and the progression from Clone  1D to F4o was  not 
always seen as clearly as shown in Fig. 4. Variation in gan- 
glioside content from experiment to experiment is consider- 
able, and does not correlate with any detectable change in 
response to PEG. We have also examined the effects of a wide 
variety of lectins on cell fusion, and although differences in 
Phospholipids,  Neutral Liplds 
Cell Line"  Clone  ID  1:1.6  F40_  Clone  IO  F16  F~)... 
SIP  Ratio: ~ 
1"33(C1.1D  )  2"38(FI6 )  Whole Ceils,  3(F40 ) 
FIGURE  8  Relative contributions of phospholipids and neutral lipids to Clone ID,  F~6, and F40 fatty acyl chain composition. In 
the upper part of the figure, the S/P ratios are given for phospholipids and neutral lipids of three cell lines (data compiled from 
Table II). S/P ratios of total cell lipids are shown on the lower line. The relative contributions of phospholipids and neutral lipids 
to the  total  cell  fatty  acid  content  is  indicated  by  the  thickness  of the  arrows. The  observed  progression toward  increased 
saturation in  increasingly PEG-resistant cells is primarily due to increasing amounts of neutral lipid, which  is highly saturated. 
Neutral lipid only makes a minor contribution to the acyl chain composition of Clone I D cells. 
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fusion response remains relatively unchanged by agglutination 
of surface sugars (data not shown). The possible role of cell 
proteins in the differential fusion of these cell  lines has also 
been examined. Although description of these experiments is 
beyond the  scope of this  report,  any differences that  have 
been observed are relatively minor and usually depend more 
on  cell  density  than  on  which  cell  line  is  examined.  By 
contrast,  both  the  increasing  levels of ether  lipid  and  the 
elevated S/P ratios observed between Clone  1D and F4o are 
highly reproducible. 
Implications of Lipid Composition for 
Membrane Fusion 
The multistep procedure required for the isolation of PEG- 
resistant cells suggests  the involvement of several factors in 
cell  fusion,  and  there  are  likely  to  be  other  biochemical 
changes that  play some role in  the  modulation  of cellular 
response to PEG. A strong argument in favor of a major role 
for the neutral lipid and fatty acid alterations described above 
is provided by studies involving lipid supplementation, pre- 
sented in the accompanying paper. By specific alteration of 
cellular  lipid  composition  we  have  been  able  to  alter  the 
fusion  response of cells in a  predictable manner.  The lipid 
modifications which alter fusion correlate directly with alkyl- 
diacylglycerol and fatty acid content, but not with the other 
factors discussed above. 
From  the  experiments presented  in  this  paper,  it  is  not 
possible to determine whether either or both of the observed 
lipid differences are responsible for the induction  of fusion 
resistance in F4o cells. At least two models can be considered. 
In the  first  model,  the  ether  lipid  component could  be of 
fundamental importance: a  cell in the process of becoming 
PEG resistant turns on the synthesis of neutral lipids, increas- 
ing triglyceride and alkyldiacylglycerol production especially. 
These  lipids are synthesized  with  the  highly saturated  acyl 
chain composition typical of neutral lipids, so that an elevated 
S/P ratio results as the byproduct of having more ether lipid. 
Alternatively,  it  may  be  that  increased  saturation  of acyl 
chains  is  responsible for the  PEG-resistant phenotype. Ac- 
cording to this second model, the ether linkage could be a 
"red herring" with no active role in the fusion process. Rather, 
the synthesis of large amounts of neutral lipid is a convenient 
way for the cell to incorporate more saturated fatty acids. The 
alkyl group of alkyldiacylglycerol may serve as some sort of 
intracellular signal, perhaps encouraging the incorporation of 
this  lipid  into  membranes in  specific microdomains which 
have been postulated as sites of  fusion. Ether lipids are unusual 
among glycerides in that they are synthesized by membrane- 
bound enzymes and may be incorporated into membranes, 
as discussed above. 
Lipid molecules may directly modulate the fusion response, 
perhaps by changing biophysical parameters at the cell mem- 
brane. It is tempting to imagine that the increased S/P ratio 
in F4o cells results in much stiffer membranes which are less 
prone to disruption  and  PEG-induced  fusion.  Results  pre- 
sented in the following paper cast doubt on this interpretation, 
however.  It is also possible that the lipids of PEG-resistant 
cells exert a  more distant regulatory effect on fusion. Many 
examples are known of lipid activation of enzymes and asso- 
ciation with other proteins, and it may be that the ether lipid 
and/or elevated S/P ratios act in this fashion. In such a model, 
even lipids which are not present at the plasma membrane 
could play a role in modulating the fusion response. 
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